Investigational Immunotherapy Combo Shows Promise for Advanced Solid Tumors

[MEDPAGE TODAY]( Oncology Update Tuesday, February 27, 2024 [Investigational Immunotherapy Combo Shows Promise for Advanced Solid Tumors]( [Changing the Surgical Paradigm in Oligometastatic NSCLC]( [Can Artificial Intelligence Improve Prior Authorization?]( [More Population-Based Evidence That Screening for CRC Reduces Risk of Cancer Death]( ADVERTISEMENT Exclusives & Features [Oregon Pathologist Reportedly Missed Cancer Diagnoses]( [Doctor Mistakenly Accused of Shouting Racist Slurs at Woman]( [Learning how to fight rather than fear cancer: A battle-hardened expert offers advice]( Kathy Giusti has fought cancer twice in 25 years and now written a book to help others combat both the disease and the health care system. [READ MORE]( [The power of empathy: a tale of two prostate biopsies]( Sitting in the hospital's urology department for a second prostate biopsy, the experience is vastly different from the first, as empathy, kindness, and warmth make all the difference in patient... [READ MORE]( [A framework for building comprehensive cancer center's capacity for bidirectional engagement.]( PURPOSE: Community engagement has benefits for cancer centers' work and for its researchers. This study examined the experiences and perceptions of community engagement by members of the Case... [READ MORE]( [Cancer patients' reproductive options in doubt after Alabama IVF ruling]( Alabama Supreme Court ruling considers frozen embryos as children, causing concern for cancer patients using IVF for future fertility. [READ MORE]( [CD38-directed, single-chain T cell-engager targets leukemia stem cells through IFNγ-induced CD38 expression.]( Treatment resistance of leukemia stem cells (LSCs) and suppression of the autologous immune system represent major challenges to achieve a cure in acute myeloid leukemia (AML). Although AML blasts... [READ MORE]( [A Property of Everyday Health group]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Spec_Oncology_Update?xid=nl_mpt_Oncology_update_2024-02-27&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011